Detalore

Detalore is a medication that belongs to the class of synthetic estranes, a type of steroid hormone. It is used to treat female pattern hair loss, a condition in which hair growth is slowed, leading to thinning and loss of hair on the scalp.

Detalore works by binding to androgen receptors, which helps to block the effects of dihydrotestosterone (DHT), a hormone that contributes to hair loss. By inhibiting the growth of DHT, detalore allows hair follicles to continue producing healthy hair. It is administered via topical application, typically in the form of a foam or solution, which is applied directly to the scalp.

The efficacy of detalore in treating female pattern hair loss was established through clinical trials, which showed significant improvements in hair density and overall hair growth after treatment. Side effects are typically mild and temporary, and may include skin irritation, itching, or redness at the site of application.

Detalore has been approved for use in countries including the United States, Canada, and several countries in the European Union. However, it is not approved for use in all countries, and its availability may be limited in certain regions. As with any medication, detalore should be used under the guidance of a healthcare professional and in accordance with the manufacturer's instructions.